1 suspended. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Suspended 1 |
Follow Aortic Dissection: new trials by email Literature Review of Aortic Dissection trials Research Report on Aortic Dissection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Investigate Efficacy, Safety, and Pharmacokinetics of Enzastaurin for the Prevention of Arterial Events in Patients With Vascular Ehlers-Danlos Syndrome. Enzastaurin, Placebo - Vascular Ehlers-Danlos Syndrome | Phase 3 | Suspended | Aytu BioPharma, Inc. | 260 | 2025-01-01 | 2024-03-08 |
Ehlers-Danlos Syndrome, Type IV (1)
Aneurysm (1) · Cardiovascular Diseases (1) · Collagen Diseases (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Connective Tissue Diseases (1) · Dissection, Blood Vessel (1) · Ehlers-Danlos Syndrome (1) · Genetic Diseases, Inborn (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hemorrhagic Disorders (1) · Hemostatic Disorders (1) · Skin Abnormalities (1)
enzastaurin (1)
United States (1)
Shaine Morris, M.D.,M.P.H. (1) · Sherene Shalhub, M.D., M.P.H. (1)